Stocklytics Platform
Asset logo for symbol PGEN
Precigen
PGEN52
$0.90arrow_drop_down0.86%-$0.00
Penny Stock
Asset logo for symbol PGEN
PGEN52

$0.90

arrow_drop_down0.86%

Performance History

Chart placeholder
Key Stats
Open$0.92
Prev. Close$0.90
EPS-0.54
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$264.34M
PE Ratio-
LOWHIGH
Day Range0.89
0.95
52 Week Range0.77
1.93
Ratios
EPS-0.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Precigen (PGEN)

Precigen Inc (PGEN) is a biotechnology company that focuses on the development of innovative gene and cell therapies to address unmet medical needs. The company utilizes its proprietary AdenoVerse technology platform to create precise and scalable genetic therapies. Precigen's goal is to revolutionize the treatment of various diseases, including cancer, genetic disorders, and infectious diseases.
With a strong focus on research and development, Precigen is continuously advancing its pipeline of therapeutic candidates. The company is at the forefront of cutting-edge technologies, such as gene editing, synthetic biology, and immunotherapy. This positions Precigen to make significant contributions to the rapidly evolving field of precision medicine.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Helen Sabzevari MPH, Ph.D.
Headquarters
Germantown
Employees
209
Exchange
NASDAQ
add Precigen  to watchlist

Keep an eye on Precigen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Precigen 's (PGEN) price per share?

The current price per share for Precigen (PGEN) is $0.9. The stock has seen a price change of -$0.01 recently, indicating a -0.86% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Precigen (PGEN)?

For Precigen (PGEN), the 52-week high is $1.93, which is 113.83% from the current price. The 52-week low is $0.78, the current price is 16.31% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Precigen (PGEN) a growth stock?

Precigen (PGEN) has shown an average price growth of -6.03% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Precigen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Precigen (PGEN) stock price performance year to date (YTD)?

As of the latest data, Precigen (PGEN) has a year-to-date price change of -35.99%. Over the past month, the stock has experienced a price change of -3.69%. Over the last three months, the change has been -19.41%. Over the past six months, the figure is -34.59%.
help

Is Precigen (PGEN) a profitable company?

Precigen (PGEN) has a net income of -$95.9M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 1.7% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -3.67K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.22M, although specific revenue growth data is currently not available. The gross profit is $106K. Operating income is noted at -$88.92M. Furthermore, the EBITDA is -$88.58M.
help

What is the market capitalization of Precigen (PGEN)?

Precigen (PGEN) has a market capitalization of $264.34M. The average daily trading volume is 0.92, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level